The use of abusable prescription drugs: The role of gender

Journal of Women's Health and Gender-Based Medicine

Volumn 9, Issue 3, 2000, Pages 289-297

  Simoni Wastila, Linda ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; HYPNOTIC AGENT; NARCOTIC ANALGESIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; DEMOGRAPHY; DRUG ABUSE; DRUG USE; ECONOMIC ASPECT; EMPLOYMENT; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SOCIAL ASPECT; URBAN AREA;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PREVALENCE; SEX CHARACTERISTICS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0034097588     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460900318470     Document Type: Article

References (42)

1. Cafferata GL, Meyers SM. Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care 1990;28:285.
2. Cottler LB, Robins LN. The prevalence and characteristics of psychoactive medication use in a general population study. Psychopharmacol Bull 1983;19:746.
3. Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care 1989;27:478.
4. Mellinger GD, Balter MB, Manheimer DI, et al. Psychic distress, life crisis, and use of psychotherapeutics. Arch Gen Psychiatry 1978;35:1045.
5. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251:375.
6. Simoni-Wastila LJ. Gender and psychotropic drug use. Med Care 1998;36:88.
7. Svarstad BL, Cleary PD, Mechanic D, Robers PA. Gender differences in the acquisition of prescribed drugs: An epidemiological study. Med Care 1987;25:1089.
8. Swartz M, Landerman R, George LK, et al. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. Am J Public Health 1991;81:592.
9. Takala J, Ryynanen O-P, Lehtovirta E, et al. The relationship between mental health and drug use. Acta Psychiatri Scand 1993;88:256.
10. Van der Waals F, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. Br Med J 1993;307:363.
11. Wells KB, Kamberg C, Brook R, et al. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care 1985;23:1295.
12. Bush PJ, Osterweis M. Pathways to medicine use. J Health Soc Behav 1978;19:179.
13. Verbrugge LM. Gender and health: An update on hypotheses and evidence. J Health Soc Behav 1985;26: 156.
14. Cooperstock R, Parnell P. Research on psychotropic drug use: A review of findings and methods. Soc Sci Med 1982;16:1179.
15. Hallfors D. Factors Affecting Long-Term Use of Benzodiazepines Among the Elderly. Unpublished dissertation. The Florence Heller Graduate School for Advanced Studies in Social Welfare, Brandeis University, October, 1992.
16. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994;254:1235.
17. Bernstein LR, Folkman S, Lazarus RS. Characterization of the use and misuse of medications by an elderly, ambulatory population. Med Care 1989;27:654.
18. Jorgensen TM, Isacson DGL, Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacoepidemiol 1993;27:1120.
19. Willcox SM, Himmelstein D, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292.
20. Szwabo PA. Substance abuse in older women. Clin Geriatr Med 1993;9:197.
21. Koch H, Campbell WG. Utilization of psychotropic drugs in office-based ambulatory care. National Ambulatory Medical Care Survey, 1980 and 1981. NCHS Advance data. Hyattesville, MD: National Center for Health Statistics, 1983.
22. United States Department of Health and Human Services, Association for Health Services Research. National Medical Care Expenditures Survey, 1987: Household Survey, Expenditures, Sources of Payment, and Population Data [Public Use Tape 18]. Volume 1: Questionnaires, Data Collection Methods, and Other Attachments. Rockville, MD: USDHHS, AHC-PR, 1993.
23. Fink JL, Marquardt KW, Simonsmeier LM, eds. Pharmacy Law Digest. St. Louis, MO: Facts and Comparisons Division, JB Lippincott Co, 1987.
24. Koch HK. The collection and processing of drug information: National Ambulatory Medical Care Survey. Vital and Health Statistics, Series 2, number 90, DHHS Pub. No. (PHS)82-1364, 1980.
25. Ben-Akiva M, Lerman SR. Discrete choice analysis: Theory and application to travel demand. Cambridge, MA: MIT Press, 1991.
26. SAS Institute. SAS procedure guide, Version 6. 3rd ed. Cary, NC: SAS Institute Inc., 1990.
27. Khandker RK, Simoni-Wastila L. Differences in prescription drug utilization and expenditures between blacks and whites in the Georgia Medicaid population. Inquiry 1998;Spring:78.
28. Wastila LJ, Bishop C. The influence of multiple copy prescription programs (MCPPs) on analgesic utilization. J Pharmaceut Care Pain Symptom Control 1996; 4:3.
29. Koch H. The management of chronic pain in office-based ambulatory care. National Ambulatory Medical Care Survey, 1981. NCHS Advance data No. 123. DHHS Pub. No. (PHS) 86-1250. Hyattsville, MD: National Center for Health Statistics, 1986.
30. Koch H, Knapp DA. Utilization of controlled drugs in office-based ambulatory care. National Ambulatory Medical Care Survey, 1985. NCHS Advance data No. 177. DHHS Pub. No. (PHS) 89-1250. Hyattsville, MD: National Center for Health Statistics, 1989.
31. Parry HJ, Balter M, Mellinger G, et al. National patterns of psychotherapeutic drug use. Arch Gen Psychiatry 1973;28:769.
32. Robins LN, Regier DA, eds. Psychiatric disorders in America. New York: Free Press, 1991.
33. Travis CB. Women and health psychology: Mental health issues. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
34. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:133.
35. Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 1981;362:161.
36. Clayton RR, Voss HL, Robbins C, Skinner WF. Gender differences in drug use: An epidemiological perspective. In: Ray BA, Braude MC, eds. Women and drugs: A new era for research. National Institute on Drug Abuse Research Monograph Series No. 65. U.S. Government Printing Office, 1986.
37. Beardsley RS, Gardocki GJ, Larson DB, et al. Prescribing of psychotropic medication by primary care physicians and psychiatrists. Arch Gen Psychiatry 1988;45:1117.
38. Hohmann AA, Larson DB, Thompson JW, Beardsley RS. Psychotropic medication prescription in U.S. ambulatory medical care. Ann Pharmacother 1991;25:85.
39. Delgado A, Lopez-Fernandez LA, De Dios Luna J. Influence of the doctor's gender in the satisfaction of the users. Med Care 1993;31:795.
40. Franks P, Clancy CM. Physician gender bias in clinical decisionmaking: Screening for cancer in primary care. Med Care 1993;31:213.
41. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medicines: Primary care, psychiatry, and other medical specialties. JAMA 1998; 279:526.
42. National Medical Expenditure Survey, 1987: Household survey, expenditures, sources of payment, and population data [Public Use Tape 18]. Rockville, MD: Agency for Health Care Policy and Research, 1993.